Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05YUI
|
||||
| Former ID |
DIB000968
|
||||
| Drug Name |
Ex vivo adenosine deaminase-transduced hematopoietic stem cell therapy
|
||||
| Synonyms |
Adenosine deaminase-transduced hematopoietic stem cell therapy; Ex vivo adenosine deaminase-transduced hematopoietic stem cell therapy (ADA-SCID)
|
||||
| Indication | Immunodeficiency [ICD9: 279.3; ICD10:D84.9] | Phase 1/2 | [551929] | ||
| Company |
San Raffaele Telethon Institute for Gene Therapy
|
||||
| Target and Pathway | |||||
| Target(s) | Adenosine deaminase | Target Info | Modulator | [551928] | |
| NetPath Pathway | TCR Signaling Pathway | ||||
| IL2 Signaling Pathway | |||||
| PANTHER Pathway | Adenine and hypoxanthine salvage pathway | ||||
| PathWhiz Pathway | Purine Metabolism | ||||
| Reactome | Purine salvage | ||||
| WikiPathways | Metabolism of nucleotides | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.